Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Development of in situ gelling and bio adhesive 5-Fluorouracil enema.

Wang LL, Zheng WS, Chen SH, Fang XQ.

PLoS One. 2013 Aug 16;8(8):e71037. doi: 10.1371/journal.pone.0071037. eCollection 2013.

2.

Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin.

Qi H, Chen W, Huang C, Li L, Chen C, Li W, Wu C.

Int J Pharm. 2007 Jun 7;337(1-2):178-87. Epub 2007 Jan 7.

PMID:
17254725
3.

Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide.

Yuan Y, Cui Y, Zhang L, Zhu HP, Guo YS, Zhong B, Hu X, Zhang L, Wang XH, Chen L.

Int J Pharm. 2012 Jul 1;430(1-2):114-9. doi: 10.1016/j.ijpharm.2012.03.054. Epub 2012 Apr 5.

PMID:
22503953
4.

Thermally reversible in situ gelling carbamazepine liquid suppository.

El-Kamel A, El-Khatib M.

Drug Deliv. 2006 Mar-Apr;13(2):143-8.

PMID:
16423803
5.

New method for ophthalmic delivery of azithromycin by poloxamer/carbopol-based in situ gelling system.

Cao F, Zhang X, Ping Q.

Drug Deliv. 2010 Sep-Oct;17(7):500-7. doi: 10.3109/10717544.2010.483255.

PMID:
20500130
6.

In vitro-in vivo evaluation of in situ gelling and thermosensitive ketoprofen liquid suppositories.

Ozgüney I, Kardhiqi A, Yıldız G, Ertan G.

Eur J Drug Metab Pharmacokinet. 2014 Dec;39(4):283-91. doi: 10.1007/s13318-013-0157-6. Epub 2013 Oct 6.

PMID:
24096820
7.

Poloxamer 188 and propylene glycol-based rectal suppository enhances anticancer effect of 5-fluorouracil in mice.

Paek SH, Xuan JJ, Choi HG, Park BC, Lee YS, Jeong TC, Jin CH, Oh YK, Kim JA.

Biol Pharm Bull. 2006 May;29(5):1060-3.

9.

In vitro and in vivo characteristics of a thermogelling rectal delivery system of etodolac.

Barakat NS.

AAPS PharmSciTech. 2009;10(3):724-31. doi: 10.1208/s12249-009-9261-y. Epub 2009 May 29.

10.

Increased bioavailability of propranolol in rats by retaining thermally gelling liquid suppositories in the rectum.

Ryu JM, Chung SJ, Lee MH, Kim CK, ShimCK.

J Control Release. 1999 May 20;59(2):163-72.

PMID:
10332051
11.
12.

Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels.

Mansour M, Mansour S, Mortada ND, Abd Elhady SS.

Drug Dev Ind Pharm. 2008 Jul;34(7):744-52. doi: 10.1080/03639040801926030 .

PMID:
18612913
13.

A novel in-situ-gelling liquid suppository for site-targeting delivery of anti-colorectal cancer drugs.

Lin HR, Tseng CC, Lin YJ, Ling MH.

J Biomater Sci Polym Ed. 2012;23(6):807-22. doi: 10.1163/092050611X560861.

PMID:
21418748
14.

Development and characterization of thermosensitive pluronic-based metronidazole in situ gelling formulations for vaginal application.

Ibrahim el-SA, Ismail S, Fetih G, Shaaban O, Hassanein K, Abdellah NH.

Acta Pharm. 2012 Mar;62(1):59-70. doi: 10.2478/v10007-012-0009-y.

PMID:
22472449
15.

Physicochemical characterization of diclofenac sodium-loaded poloxamer gel as a rectal delivery system with fast absorption.

Yong CS, Sah H, Jahng Y, Chang HW, Son JK, Lee SH, Jeong TC, Rhee JD, Baek SH, Kim CK, Choi HG.

Drug Dev Ind Pharm. 2003 May;29(5):545-53.

PMID:
12779284
16.

Preparation and evaluation of Eudragit gels. VIII. Rectal absorption of 5-fluorouracil from Eudispert hv gels in rats.

Umejima H, Kikuchi A, Kim NS, Uchida T, Goto S.

J Pharm Sci. 1995 Feb;84(2):199-202.

PMID:
7738801
17.

Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement.

Yun M, Choi H, Jung J, Kim C.

Int J Pharm. 1999 Nov 5;189(2):137-45.

PMID:
10536242
18.

Poloxamer 407 as a thermogelling and adhesive polymer for rectal administration of short-chain fatty acids.

Charrueau C, Tuleu C, Astre V, Grossiord JL, Chaumeil JC.

Drug Dev Ind Pharm. 2001 Apr;27(4):351-7.

PMID:
11411903
19.

Modulation of the rheological and mucoadhesive properties of thermosensitive poloxamer-based hydrogels intended for the rectal administration of quinine.

Koffi AA, Agnely F, Ponchel G, Grossiord JL.

Eur J Pharm Sci. 2006 Mar;27(4):328-35. Epub 2005 Dec 13.

PMID:
16356700
20.

Design and evaluation of ondansetron liquid suppository for the treatment of emesis.

Ban E, Kim CK.

Arch Pharm Res. 2013 May;36(5):586-92. doi: 10.1007/s12272-013-0049-y. Epub 2013 Feb 22.

PMID:
23430761

Supplemental Content

Support Center